Hu et al. pioneered the identification of molecular dissection in angiogenesis phenotyping [123], and Sandmann et al. did so in angiostatic targeting, identifying four molecular subtypes in IDH1 wild-type glioblastoma based on gene expression data [124], looking at the response of patients as classified according to molecular subtypes, which have been developed from publicly available databases. The gene discussed is IDH1; the disease is glioblastoma.